RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sensyne Health Stock

Sensyne Health Equity 2024

Sensyne Health Equity

52.73 M GBP

Ticker

SENS.L

ISIN

GB00BYV3J755

WKN

A2N38D

In 2024, Sensyne Health's equity was 52.73 M GBP, a 0% increase from the 0 GBP equity in the previous year.

Sensyne Health Aktienanalyse

What does Sensyne Health do?

Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. History: Sensyne Health was founded by Lord Drayson, a British entrepreneur and former Minister for Science and Innovation. The company is based on the belief that the application of AI technologies in the healthcare industry can help improve medical care, make the healthcare system more efficient, and ultimately save lives. Business model: Sensyne Health offers a range of products and services based on AI technologies. The key business areas include: - Clinical research: Sensyne Health works closely with national health authorities and various hospitals to collect and analyze data that can be used in the development of new treatment options and the improvement of diagnostic processes. - Digital patient monitoring: The company develops advanced sensors and devices that allow doctors and nurses to monitor the health status of patients in real-time. By using AI algorithms, health problems can be detected and treated early. - AI-based analysis: Sensyne Health has extensive experience in applying AI technologies to medical data. The company uses its expertise to conduct complex data analysis that helps doctors and researchers gain new insights into diseases and their treatment options. Products: Sensyne Health offers a variety of products and solutions tailored to the needs of the healthcare industry. Here are some of the key products that the company offers: - Patient data platform: A cloud-based platform that allows hospitals and research institutions to collect, store, and analyze patient data. The use of AI algorithms automates and accelerates data analysis. - Hospital collaborations: Sensyne Health works with various hospitals in the UK and other countries to collect and analyze patient data. The data is then shared in anonymized form with researchers and life science companies to develop new insights and treatment options. - AI-based patient monitoring: Sensyne Health has developed a range of devices and sensors that allow doctors and nurses to monitor the health status of patients in real-time. The data is automatically evaluated, and the results are transmitted to the medical staff to quickly respond to changes in the patient's condition. Conclusion: Sensyne Health is a leading provider of AI-based solutions for the healthcare industry. The company specializes in data collection, analysis, and the development of new treatment options. Through its collaborations with hospitals and government agencies, Sensyne Health has access to a large amount of data that can lead to new insights and improve medical care in the future. Answer: Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. The company was founded by Lord Drayson, and it aims to use AI technologies to improve medical care, make healthcare more efficient, and save lives. Sensyne Health offers products and services in clinical research, digital patient monitoring, and AI-based analysis. The company's products include a patient data platform, collaborations with hospitals, and AI-based patient monitoring devices. Sensyne Health is focused on collecting and analyzing data to develop new treatment options and improve healthcare in the future. Sensyne Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sensyne Health's Equity

Sensyne Health's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sensyne Health's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sensyne Health's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sensyne Health's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sensyne Health’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sensyne Health stock

What is the equity of Sensyne Health this year?

Sensyne Health has equity of 52.73 M GBP this year.

What was the equity of Sensyne Health compared to the previous year?

The equity of Sensyne Health has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Sensyne Health?

A high equity is advantageous for investors of Sensyne Health as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sensyne Health?

A low equity can be a risk for investors of Sensyne Health, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sensyne Health affect the company?

An increase in equity of Sensyne Health can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sensyne Health affect the company?

A reduction in equity of Sensyne Health can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sensyne Health?

Some factors that can affect the equity of Sensyne Health include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sensyne Health so important for investors?

The equity of Sensyne Health is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sensyne Health take to change the equity?

To change equity, Sensyne Health can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sensyne Health pay?

Over the past 12 months, Sensyne Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensyne Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Sensyne Health?

The current dividend yield of Sensyne Health is .

When does Sensyne Health pay dividends?

Sensyne Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensyne Health?

Sensyne Health paid dividends every year for the past 0 years.

What is the dividend of Sensyne Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensyne Health located?

Sensyne Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensyne Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensyne Health from 10/15/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.

When did Sensyne Health pay the last dividend?

The last dividend was paid out on 10/15/2024.

What was the dividend of Sensyne Health in the year 2023?

In the year 2023, Sensyne Health distributed 0 GBP as dividends.

In which currency does Sensyne Health pay out the dividend?

The dividends of Sensyne Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sensyne Health

Our stock analysis for Sensyne Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensyne Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.